Kambiz N. Alavian

Loading
loading..

Reader in Neuroscience

Department of Brain Sciences ■ Imperial College, LondonHammersmith Hospital ■ DuCane Road ■ London, UK ■ W12 0NNTel: 020 7594 7006 ■ Email: k.alavian@imperial.ac.uk  ■ http://alavianlab.org/

 

PROFESSIONAL HISTORY

 

Academic appointments

                                                                                                                           

2023 –

Reader in Neuroscience (Tenured)

Imperial College London

Department of Brain Sciences, London, UK

2020 –

Associate Professor Adjunct

Yale University, School of Medicine

Department of Internal Medicine, Endocrinology, New Haven, CT

2020 – 2023

Senior Lecturer (Tenured Associate Professor)

Imperial College London

Department of Brain Sciences, London, UK

2013 – 2020

Lecturer (Assistant Professor)

Imperial College London

Department of Brain Sciences, London, UK

2013 – 2020

Assistant Professor Adjunct

Yale University, School of Medicine

Department of Internal Medicine, Endocrinology, New Haven, CT

2010 – 2013

Associate Research Scientist

Yale University, School of Medicine,

Department of Internal Medicine, Endocrinology, New Haven, CT.

2008 – 2010

Postdoctoral Associate

Yale University School of Medicine

Department of Internal Medicine, Endocrinology, New Haven, CT

2006 – 2008

Postdoctoral Fellow

Harvard Medical School

McLean Hospital, Belmont, MA

 

Other professional appointments & leadership

2024 –

Director of Education

Department of Brain Sciences, Imperial College London

2023 –

PI: Global Ageing Research Consortium (UK-North America)

UKRI (BBSRC & MRC)

2022 –

Joint Director: Muscle Resilience across the life course (MyAge) Network

UKRI (BBSRC & MRC)

2022 –

Deputy Director: UK Ageing Research Network

UKRI (BBSRC & MRC)

2021 –

Member – Biology Education Research Group (BERG)

Royal Society of Biology, UK

2021 –

Lead Academic Founder, Director & CEO

GlioQuell Limited, London, UK

2021 –

Founding Director

Insurgiac Corporation, Delaware, USA

2021 –

Founding Director and Board Member

Watch All Night Foundation, USA

2020 –

Member of College of Experts

Parkinson’s UK

        

EDUCATION

                                                                                                                           

2006

PhD, Neuroscience

University of Heidelberg, Germany

2003

Master of Science (MSc), Biology

Illinois Institute of Technology, Chicago, IL.

2021

Master’s in Education (MEd), University Learning and Teaching

Imperial College London

2001

Bachelor of Science (BSc), Biology

University of Illinois at Chicago, IL.

 

HONOURS & AWARDS

 

2022 –

Fellow of the Linnean Society of London (FLS)

The Linnean Society of London, UK

2020 –

Fellow of the Royal Society of Biology (FRSB)

Royal Society of Biology, UK

2018 –

Senior Fellow of the Higher Education Academy (SFHEA)

The Higher Education Academy (FHEA), UK

2017 & 2018

Whitman Center Research Fellow

Marine Biological Laboratory, Woods Hole, MA

2016-2018

Fellow of the Higher Education Academy (FHEA)

The Higher Education Academy (FHEA), UK

2012

The Young Bioenergeticist Award

Biophysical Society

2007-2008

Molecular Biology of Neurodegeneration Fellow

Harvard Medical School

2007-2008

Member of AAAS/Science Program for Excellence in Science

The American Association for the Advancement of Science

2002-2003

Dean’s Scholarship Recipient

Illinois Institute of Technology

1999-2001

Member of Honors College

University of Illinois

1998-1999

Member of Phi Theta Kappa International Honor Society

Phi Theta Kappa International Honor Society

PUBLICATIONS

  • Short, E., Adcock, I. M., Al-Sarireh, B., Ager, A., Ajjan, R., Akbar, N., Akeroyd, M. A., Alsaleh, G., Al-Sharbatee, G., Alavian, K., Amoaku, W., . . . Iccarp. (2024). Defining an ageing-related pathology, disease or syndrome: International Consensus Statement. GeroScience. https://doi.org/10.1007/s11357-024-01315-9
  • MacColl Garfinkel, A, Mnatsakanyan, N, Patel, JH, Wills, AE, Shteyman, A, Smith, PJS, Alavian, KN, Jonas, EA and Khokha, MK. Mitochondrial leak metabolism induces the Spemann-Mangold Organizer via Hif-1α. Developmental Cell. 2023, doi: 10.1016/j.devcel.2023.08.015
  • Sharifi P, Bae H, Gveric D, Gentleman SM, Smith PJS, Tierney TS, Alavian KN: CAV2.3 expression is upregulated in the substantia nigra pars compacta of humans with Parkinson’s disease. Brain Disorders 2022, 5:100031.
  • Tierney TS, Alavian KN, Altman N, Bhatia S, Duchowny M, Hyslop A, Jayakar P, Resnick T, Wang S, Miller I, Ragheb J: Initial experience with magnetic resonance–guided focused ultrasound stereotactic surgery for central brain lesions in young adults. Journal of Neurosurgery 2022:1-8.d
  • Sandrone S, Alavian KN: Threshold Concepts in Neuroscience: Identification Challenges, Educational Opportunities and Recommendations for Practice. Frontiers in Education 2021, 5.
  • Niu Y, Moghimyfiroozabad S, Moghimyfiroozabad A, Tierney TS, Alavian KN: The factors for the early and late development of midbrain dopaminergic neurons segregate into two distinct evolutionary clusters. Brain Disorders 2021, 1:100002.
  • Alavian KN, Yu J-T: Disorders of the brain, paradoxes of the enigma (editorial). Brain Disorders 1. pp. 100003: Elsevier; 2021:100003.
  • Weinert M, Millet A, Jonas EA, Alavian KN: The mitochondrial metabolic function of DJ-1 is modulated by 14-3-3beta. FASEB J 2019:fj201802754R.
  • Mallach A, Weinert M, Arthur J, Gveric D, Tierney TS, Alavian KN: Post mortem examination of Parkinson’s disease brains suggests decline in mitochondrial biomass, reversed by deep brain stimulation of subthalamic nucleus. FASEB J 2019:fj201802628R.
  • Fang Y, Liu C, Lin J, Li X, Alavian KN, Yang Y, Niu Y: PhySpeTree: an automated pipeline for reconstructing phylogenetic species trees. BMC Evol Biol 2019, 19:219.
  • Chen R, Park HA, Mnatsakanyan N, Niu Y, Licznerski P, Wu J, Miranda P, Graham M, Tang J, Boon AJW, Cossu G, Mandemakers W, Bonifati V, Smith PJS, Alavian KN, Jonas EA: Parkinson’s disease protein DJ-1 regulates ATP synthase protein components to increase neuronal process outgrowth. Cell Death Dis 2019, 10:469.
  • Park HA, Licznerski P, Mnatsakanyan N, Niu Y, Sacchetti S, Wu J, Polster BM, Alavian KN, Jonas EA: Inhibition of Bcl-xL prevents pro-death actions of DeltaN-Bcl-xL at the mitochondrial inner membrane during glutamate excitotoxicity. Cell Death Differ
  • Niu Y, Moghimyfiroozabad S, Safaie S, Yang Y, Jonas EA, Alavian KN: Phylogenetic Profiling of Mitochondrial Proteins and Integration Analysis of Bacterial Transcription Units Suggest Evolution of F1Fo ATP Synthase from Multiple Modules. Journal of Molecular Evolution
  • Niu Y, Liu C, Moghimyfiroozabad S, Yang Y, Alavian KN: PrePhyloPro: phylogenetic profile-based prediction of whole proteome linkages. PeerJ 2017, 5:e3712.
  • Jonas EA, Porter GA, Beutner G, Mnatsakanyan N, Park H-A, Mehta N, Chen R, Alavian KN: The Mitochondrial Permeability Transition Pore: Molecular Structure and Function in Health and Disease. In Molecular Basis for Mitochondrial Signaling. Edited by Rostovtseva TK. Cham: Springer International Publishing; 2017: 69-105
  • Beutner G, Alavian KN, Jonas EA, Porter GA, Jr.: The Mitochondrial Permeability Transition Pore and ATP Synthase. Handb Exp Pharmacol 2017, 240:21-46.
  • Mnatsakanyan N, Beutner G, Porter GA, Alavian KN, Jonas EA: Physiological roles of the mitochondrial permeability transition pore. J Bioenerg Biomembr
  • Jonas EA, Porter GA, Beutner G, Mnatsakanyan N, Alavian KN: The Mitochondrial Permeability Transition Pore, the c-Subunit of the F1Fo ATP Synthase, Cellular Development, and Synaptic Efficiency. In The Functions, Disease-Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria. John Wiley & Sons, Inc; 2016: 31-64
  • Weinert M, Selvakumar T, Tierney TS, Alavian KN: Isolation, culture and long-term maintenance of primary mesencephalic dopaminergic neurons from embryonic rodent brains. J Vis Exp
  • Selvakumar T, Alavian KN, Tierney T: Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus. J Vis Exp 2015:e52457.
  • Park HA, Licznerski P, Alavian KN, Shanabrough M, Jonas EA: Bcl-xL is necessary for neurite outgrowth in hippocampal neurons. Antioxid Redox Signal 2015, 22:93-108.
  • Licznerski P, Duric V, Banasr M, Alavian KN, Ota KT, Kang HJ, Jonas EA, Ursano R, Krystal JH, Duman RS, Traumatic Stress Brain Study G: Decreased SGK1 Expression and Function Contributes to Behavioral Deficits Induced by Traumatic Stress. PLoS Biol 2015, 13:e1002282.
  • Jonas EA, Porter GA, Jr., Beutner G, Mnatsakanyan N, Alavian KN: Cell death disguised: The mitochondrial permeability transition pore as the c-subunit of the FF ATP synthase. Pharmacol Res
  • Cotroneo E, Ashek A, Wang L, Wharton J, Dubois OD, Bozorgi SS, Busbridge M, Alavian KN, Wilkins MR, Zhao L: Iron Homeostasis and Pulmonary Hypertension: Iron Deficiency Leads to Pulmonary Vascular Remodeling in the Rat. Circ Res
  • Alavian KN, Dworetzky SI, Bonanni L, Zhang P, Sacchetti S, Li H, Signore AP, Smith PJ, Gribkoff VK, Jonas EA: The mitochondrial complex V-associated large-conductance inner membrane current is regulated by cyclosporine and dexpramipexole. Mol Pharmacol 2015, 87:1-8.
  • Jonas EA, Porter GA, Alavian KN: Bcl-xL in neuroprotection and plasticity. Front Physiol 2014, 5:355.
  • Alavian KN, Jeddi S, Naghipour SI, Nabili P, Licznerski P, Tierney TS: The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed. J Biomed Sci 2014, 21:27.
  • Alavian KN, Beutner G, Lazrove E, Sacchetti S, Park HA, Licznerski P, Li H, Nabili P, Hockensmith K, Graham M, Porter GA, Jr., Jonas EA: An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA (PNAS) 2014, 111:10580-10585.
  • Sacchetti S, Alavian KN, Lazrove E, Jonas EA: F1FO ATPase vesicle preparation and technique for performing patch clamp recordings of submitochondrial vesicle membranes. J Vis Exp 2013:e4394.
  • Li H, Alavian KN, Lazrove E, Mehta N, Jones A, Zhang P, Licznerski P, Graham M, Uo T, Guo J, Rahner C, Duman RS, Morrison RS, Jonas EA: A Bcl-xL-Drp1 complex regulates synaptic vesicle membrane dynamics during endocytosis. Nature Cell Biology 2013, 15:773-785.
  • Ofengeim D, Chen YB, Miyawaki T, Li H, Sacchetti S, Flannery RJ, Alavian KN, Pontarelli F, Roelofs BA, Hickman JA, Hardwick JM, Zukin RS, Jonas EA: N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nature Neuroscience 2012, 15:574-580.
  • Gray JP, Alavian KN, Jonas EA, Heart EA: NAD kinase regulates the size of the NADPH pool and insulin secretion in pancreatic beta-cells. Am J Physiol Endocrinol Metab 2012, 303:E191-199.
  • Alavian KN, Dworetzky SI, Bonanni L, Zhang P, Sacchetti S, Mariggio MA, Onofrj M, Thomas A, Li H, Mangold JE, Signore AP, Demarco U, Demady DR, Nabili P, Lazrove E, Smith PJ, Gribkoff VK, Jonas EA: Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency. Brain Res 2012, 1446:1-11.
  • Sanchez CE, Tierney TS, Gale JT, Alavian KN, Sahin A, Lee JS, Mulligan RC, Carter BS: Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. J Neurosurg 2011, 114:672-680.
  • Chen YB, Aon MA, Hsu YT, Soane L, Teng X, McCaffery JM, Cheng WC, Qi B, Li H, Alavian KN, Dayhoff-Brannigan M, Zou S, Pineda FJ, O’Rourke B, Ko YH, Pedersen PL, Kaczmarek LK, Jonas EA, Hardwick JM: Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 2011, 195:263-276.
  • Alavian KN, Li H, Collis L, Bonanni L, Zeng L, Sacchetti S, Lazrove E, Nabili P, Flaherty B, Graham M, Chen Y, Messerli SM, Mariggio MA, Rahner C, McNay E, Shore GC, Smith PJ, Hardwick JM, Jonas EA: Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nature Cell Biology 2011, 13:1224-1233.
  • Vahedi S, Rajabian M, Misaghian A, Grbec D, Simon HH, Alavian KN: Parkinson’s disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons. J Biomed Sci 2010, 17:66.
  • Chung CY, Licznerski P, Alavian KN, Simeone A, Lin Z, Martin E, Vance J, Isacson O: The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons. Brain 2010, 133:2022-2031.
  • Simon HH, Alavian KN: Transcriptional regulation of their survival: the Engrailed homeobox genes. Adv Exp Med Biol 2009, 651:66-72.
  • Pruszak J, Ludwig W, Blak A, Alavian K, Isacson O: CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells 2009, 27:2928-2940.
  • Alavian KN, Simon HH: Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database. Mol Neurodegener 2009, 4:6.
  • Alavian KN, Sgado P, Alberi L, Subramaniam S, Simon HH: Elevated P75NTR expression causes death of engrailed-deficient midbrain dopaminergic neurons by Erk1/2 suppression. Neural Dev 2009, 4:11.
  • Alavian KN, Scholz C, Simon HH: Transcriptional regulation of mesencephalic dopaminergic neurons: the full circle of life and death. Mov Disord 2008, 23:319-328.
  • Sgado P, Alberi L, Gherbassi D, Galasso SL, Ramakers GM, Alavian KN, Smidt MP, Dyck RH, Simon HH: Slow progressive degeneration of nigral dopaminergic neurons in postnatal Engrailed mutant mice. Proc Natl Acad Sci USA (PNAS) 2006, 103:15242-15247.
  • Thuret S, Alavian KN, Gassmann M, Lloyd CK, Smits SM, Smidt MP, Klein R, Dyck RH, Simon HH: The neuregulin receptor, ErbB4, is not required for normal development and adult maintenance of the substantia nigra pars compacta. J Neurochem 2004, 91:1302-1311.

Layout mode
Predefined Skins
Custom Colors
Choose your skin color
Patterns Background
Images Background